Switch to:
Also traded in: Australia, Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 0.06
UNIS's Cash to Debt is ranked lower than
94% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. UNIS: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
UNIS' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.56 Max: N/A
Current: 0.06
Equity to Asset -1.39
UNIS's Equity to Asset is ranked lower than
98% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. UNIS: -1.39 )
Ranked among companies with meaningful Equity to Asset only.
UNIS' s Equity to Asset Range Over the Past 10 Years
Min: -1.39  Med: 0.52 Max: 0.79
Current: -1.39
-1.39
0.79
F-Score: 3
Z-Score: -12.83
M-Score: -7.18
WACC vs ROIC
5.81%
-924.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -710.61
UNIS's Operating margin (%) is ranked lower than
93% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. UNIS: -710.61 )
Ranked among companies with meaningful Operating margin (%) only.
UNIS' s Operating margin (%) Range Over the Past 10 Years
Min: -2225.96  Med: -611.25 Max: -1.77
Current: -710.61
-2225.96
-1.77
Net-margin (%) -694.94
UNIS's Net-margin (%) is ranked lower than
93% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. UNIS: -694.94 )
Ranked among companies with meaningful Net-margin (%) only.
UNIS' s Net-margin (%) Range Over the Past 10 Years
Min: -2303.97  Med: -611.76 Max: -2.59
Current: -694.94
-2303.97
-2.59
ROA (%) -94.36
UNIS's ROA (%) is ranked lower than
96% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. UNIS: -94.36 )
Ranked among companies with meaningful ROA (%) only.
UNIS' s ROA (%) Range Over the Past 10 Years
Min: -109.51  Med: -61.32 Max: -1.74
Current: -94.36
-109.51
-1.74
ROC (Joel Greenblatt) (%) -123.59
UNIS's ROC (Joel Greenblatt) (%) is ranked lower than
79% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. UNIS: -123.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UNIS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -156.25  Med: -100.44 Max: -4.02
Current: -123.59
-156.25
-4.02
Revenue Growth (3Y)(%) -32.80
UNIS's Revenue Growth (3Y)(%) is ranked lower than
94% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. UNIS: -32.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UNIS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -48  Med: 47.15 Max: 142.9
Current: -32.8
-48
142.9
EBITDA Growth (3Y)(%) -54.70
UNIS's EBITDA Growth (3Y)(%) is ranked lower than
98% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. UNIS: -54.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UNIS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -54.7  Med: 118.9 Max: 154.7
Current: -54.7
-54.7
154.7
EPS Growth (3Y)(%) -55.10
UNIS's EPS Growth (3Y)(%) is ranked lower than
94% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. UNIS: -55.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UNIS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -55.1  Med: 124.1 Max: 239.1
Current: -55.1
-55.1
239.1
» UNIS's 10-Y Financials

Financials (Next Earnings Date: 2017-02-09)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

UNIS Guru Trades in Q2 2015

Jim Simons 27,774 sh (New)
Ron Baron 333,477 sh (-52.49%)
» More
Q3 2015

UNIS Guru Trades in Q3 2015

Ron Baron Sold Out
Jim Simons Sold Out
» More
Q4 2015

UNIS Guru Trades in Q4 2015

Jim Simons 352,501 sh (New)
» More
Q1 2016

UNIS Guru Trades in Q1 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:AMEX:INFU, AMEX:MLSS, NAS:CASM, NAS:ATEC, NAS:LENS, AMEX:ISR, AMEX:DXR, NAS:BLFS, NAS:PDEX, NAS:BMRA, NAS:SKLN, OTCPK:REPR, OTCBB:NEPH, OTCPK:STXS, AMEX:RVP, NAS:DXTR, NAS:AKER, OTCPK:SOAN, NAS:NURO, NAS:SSKN » details
Traded in other countries:UNS.Australia, 4UL1.Germany, UNISZ.USA,
Unilife Corp is a designer, manufacturer and supplier of injectable drug delivery systems. Its product include pre-filled syringes, wearable injectors, disposable & reusable auto-injectors, drug reconstitution delivery systems & other systems.

Unilife Corp was incorporated under the laws of the State of Delaware in 2009 and is based in the Commonwealth of Pennsylvania. The Company is a designer, manufacturer, and supplier of injectable drug delivery systems that can enhance and differentiate the injectable products of its pharmaceutical and biotechnology customers. It has developed several product platforms, including its Unifill platform of pre-filled syringes, its LISA smart reusable and RITA disposable auto-injectors, its EZMix platform of drug reconstitution delivery systems, and its Ocu-ject, Ocu-mix, and Depot-ject ocular delivery systems. The Company's product portfolio comprises of proprietary product platforms, including wearable injectors, insulin delivery systems, disposable and reusable auto-injectors, pre-filled syringes, drug reconstitution delivery systems, ocular delivery systems and other systems for the targeted delivery of injectable therapies.

Ratios

vs
industry
vs
history
P/E(ttm) 0.18
UNIS's P/E(ttm) is ranked higher than
99% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.70 vs. UNIS: 0.18 )
Ranked among companies with meaningful P/E(ttm) only.
UNIS' s P/E(ttm) Range Over the Past 10 Years
Min: 0.13  Med: 0.21 Max: 0.33
Current: 0.18
0.13
0.33
PE(NRI) 0.18
UNIS's PE(NRI) is ranked higher than
99% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.99 vs. UNIS: 0.18 )
Ranked among companies with meaningful PE(NRI) only.
UNIS' s PE(NRI) Range Over the Past 10 Years
Min: 0.13  Med: 0.21 Max: 0.33
Current: 0.18
0.13
0.33
P/S 0.55
UNIS's P/S is ranked higher than
91% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.98 vs. UNIS: 0.55 )
Ranked among companies with meaningful P/S only.
UNIS' s P/S Range Over the Past 10 Years
Min: 0.39  Med: 24.13 Max: 85.65
Current: 0.55
0.39
85.65
EV-to-EBIT -1.82
UNIS's EV-to-EBIT is ranked lower than
99.99% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.14 vs. UNIS: -1.82 )
Ranked among companies with meaningful EV-to-EBIT only.
UNIS' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.6  Med: -4.4 Max: -0.6
Current: -1.82
-19.6
-0.6
EV-to-EBITDA -1.96
UNIS's EV-to-EBITDA is ranked lower than
99.99% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. UNIS: -1.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
UNIS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -21.9  Med: -4.8 Max: -0.6
Current: -1.96
-21.9
-0.6
PEG 0.01
UNIS's PEG is ranked higher than
98% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.68 vs. UNIS: 0.01 )
Ranked among companies with meaningful PEG only.
UNIS' s PEG Range Over the Past 10 Years
Min: 0  Med: 0 Max: N/A
Current: 0.01
Current Ratio 0.56
UNIS's Current Ratio is ranked lower than
95% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. UNIS: 0.56 )
Ranked among companies with meaningful Current Ratio only.
UNIS' s Current Ratio Range Over the Past 10 Years
Min: 0.32  Med: 1.58 Max: 8.01
Current: 0.56
0.32
8.01
Quick Ratio 0.56
UNIS's Quick Ratio is ranked lower than
91% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. UNIS: 0.56 )
Ranked among companies with meaningful Quick Ratio only.
UNIS' s Quick Ratio Range Over the Past 10 Years
Min: 0.32  Med: 1.58 Max: 7.77
Current: 0.56
0.32
7.77
Days Sales Outstanding 55.98
UNIS's Days Sales Outstanding is ranked higher than
61% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. UNIS: 55.98 )
Ranked among companies with meaningful Days Sales Outstanding only.
UNIS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.71  Med: 49.5 Max: 133.99
Current: 55.98
0.71
133.99

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -22.10
UNIS's 3-Year Average Share Buyback Ratio is ranked lower than
83% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. UNIS: -22.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UNIS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -30.1  Med: -20.35 Max: 31.4
Current: -22.1
-30.1
31.4

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.02
UNIS's Price/Median PS Value is ranked higher than
99% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.08 vs. UNIS: 0.02 )
Ranked among companies with meaningful Price/Median PS Value only.
UNIS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.02  Med: 1.03 Max: 2.2
Current: 0.02
0.02
2.2
Earnings Yield (Greenblatt) (%) -54.90
UNIS's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. UNIS: -54.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UNIS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -115.87  Med: 0 Max: 0
Current: -54.9
-115.87
0

More Statistics

Revenue (TTM) (Mil) $13.37
EPS (TTM) $ 13.48
Beta-1.05
Short Percentage of Float11.83%
52-Week Range $1.58 - 12.90
Shares Outstanding (Mil)17.38
» More Articles for UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 14 2012 
Weekly CEO Buys Highlight: UNIS, ESL, TREE, TPGI, VAC Jan 08 2012 
Weekly CEO Buys Highlight: BFS, NCT, NL, UNIS, MSCI Oct 01 2011 
Weekly CEO Buys Highlight: RCL, CIT, PNK, EXE, UNIS Aug 27 2011 
Weekly CEO Buys Highlight: DELL, DEER, BGCP, UNIS, KSWS Mar 19 2011 
Unilife Corp. (UNIS) CEO Alan Shortall buys 105,452 Shares Mar 17 2011 
Unilife Corp. Reports Operating Results (10-Q) Feb 14 2011 

More From Other Websites
ETFs with exposure to Unilife Corp. : December 1, 2016 Dec 01 2016
Unilife Corp. :UNIS-US: Earnings Analysis: Q1, 2017 By the Numbers : November 30, 2016 Nov 30 2016
Edited Transcript of UNIS earnings conference call or presentation 2-Nov-16 8:30pm GMT Nov 23 2016
UNILIFE CORP Financials Nov 17 2016
UNILIFE CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 17 2016
UNILIFE CORP Files SEC form 10-Q, Quarterly Report Nov 14 2016
Unilife Corporation to Present at the Jefferies Global Healthcare Conference Nov 10 2016
Unilife Corporation Provides Business Update Nov 02 2016
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 02 2016
Unilife Corporation Provides Business Update Nov 02 2016
ETF’s with exposure to Unilife Corp. : November 1, 2016 Nov 01 2016
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 31 2016
Unilife Corp. :UNIS-US: Earnings Analysis: 2016 By the Numbers : October 31, 2016 Oct 31 2016
Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors; Unilife Announces Date... Oct 31 2016
Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors; Unilife Announces Date... Oct 31 2016
Unilife Announces Filing of 2016 10-K Oct 24 2016
UNILIFE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Oct 24 2016
Unilife Announces Filing of 2016 10-K Oct 24 2016
UNILIFE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Oct 05 2016
Unilife Corporation Provides Trading Update Sep 29 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)